Clinical trial
Sodium-Glucose Co-Transporter-2 Inhibitors in Lupus Nephritis
NCT07323524 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sodium-Glucose Co-Transporter-2 Inhibitors in Lupus Nephritis
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- May 19, 2026
- Completion date
- January 31, 2030
- Enrollment
- 33 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
lupus nephritis (ln)